SCHEMBL10620674

SCHEMBL10620674

N#Cc1ncn([C@@H]2O[C@H](COC(=O)c3ccccc3)[C@@H](O)[C@H]2O)c1O

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ LMNA P02545 1/20 0.50
▸ ABCB1 P08183 1/20 0.49
▸ HTT P42858 1/20 0.48
▸ GSK3A P49840 6/20 0.48
▸ RPS6KA3 P51812 6/20 0.48
▸ MAPK14 Q16539 6/20 0.48
▸ PNP P00491 1/20 0.46
▸ HINT1 P49773 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10620690 0.86 MEN1 (0.54) ALDH1A1LMNAHTT
SCHEMBL10623372 0.84 ALDH1A1 (0.46) ALDH1A1LMNAHTTGSK3ARPS6KA3
SCHEMBL10708875 0.81 ALDH1A1 (0.52) ALDH1A1LMNAHTTPNP
SCHEMBL9298395 0.80 LMNA (0.64) LMNAABCB1GSK3ARPS6KA3MAPK14
SCHEMBL8987656 0.80 LMNA (0.64) LMNAABCB1GSK3ARPS6KA3MAPK14
SCHEMBL10708190 0.78 ALDH1A1 (0.49) ALDH1A1LMNAABCB1HTTGSK3A
SCHEMBL10623398 0.78 ALDH1A1 (0.60) ALDH1A1LMNAHTT
SCHEMBL11644877 0.77 ABCB1 (0.77) LMNAABCB1GSK3ARPS6KA3MAPK14
SCHEMBL441535 0.77 ABCB1 (0.77) LMNAABCB1GSK3ARPS6KA3MAPK14
SCHEMBL5746383 0.76 MEN1 (0.54) ALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0155164-B1 NOVEL CYANOIMIDAZOLE NUCLEOSIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-11-17 — — EP claimed
US-4728729-A ANTITUMOR, IMMUNOSUPPRESSANT SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1988-03-01 — — US claimed
US-4728729-A ANTITUMOR, IMMUNOSUPPRESSANT SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1988-03-01 — — US disclosed
Send feedback